Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma. - Wikidata - awgldk - TriplyDB

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

http://www.wikidata.org/entity/Q37309920

about

Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles.Effect of densely ionizing radiation on cardiomyocyte differentiation from human-induced pluripotent stem cells.

P2860

Q37389371-4117B445-7164-49C9-A77E-61A74B805878 Q41385806-13CA67B9-C7BF-4AB8-A8BD-A486D1F3A54D

P2860

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

http://www.wikidata.org/entity/Q37309920

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@en

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@nl

type

label

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@en

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@nl

prefLabel

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@en

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@nl

P1433

Q37309920-C91C4C4E-1D5F-4B77-9896-1AC07B91458E

P1476

Q37309920-DF7727AB-93E8-4AFE-8902-23ED54B0952A

P2093

Q37309920-53AB4F9A-1FAA-4A3C-AE0A-2B448D6FDA13

Q37309920-8C5D8DB2-22D9-4E8B-BC22-9B4265CED2DB

Q37309920-8E524278-C6CE-4F79-A1CD-C9AAA5D59C4C

Q37309920-98A804D6-2E43-4C95-B76E-9D4609CBF839

Q37309920-B1FF9243-EC19-4298-981F-CC750B6B0273

Q37309920-E81DF5FA-8351-430D-BF07-7D550E79F65F

Q37309920-F29FE8CD-BAA4-41BB-A251-735D56531CB3

Q37309920-FF6D2522-2C61-47FF-80B5-918347D75534

P2860

Q37309920-0DB61508-7BD4-45CA-9674-B1991F416FE4

Q37309920-1B26B99A-191D-469D-A98C-DED543829BE9

Q37309920-1F0454AB-CB1D-4D0B-AA08-8BF1860F2FA1

Q37309920-1FD8BDD9-B6FE-42B0-9D52-3E75480ABDAD

Q37309920-24B52416-1EDF-4E20-B813-78C9ED0AB5F9

Q37309920-3427D3FE-5441-406D-8FD8-5E810935205C

Q37309920-36DA8048-1D30-4AF1-A7F8-CBD4E59BB11C

Q37309920-3FBBF062-AB74-4A60-A9C3-AD4B06C159A3

Q37309920-4CF4021A-DD33-4717-A91B-3F8503582A2F

Q37309920-4E1AAE86-E921-4692-8440-68F830E4A06F

P304

Q37309920-2E9785D4-C455-4559-B14F-EA42520DC467

P31

Q37309920-BCB4F478-8B99-408D-B872-631B2CACC804

P356

Q37309920-DA481A28-C5E2-48FD-96EB-F4D783099141

P407

Q37309920-F18A0A3F-5F43-48ED-8C36-AE3A81C6A936

P433

Q37309920-FD833D64-C5BF-4E76-A456-0D5019BB7E26

P478

Q37309920-A36A4B9F-0683-45EE-A3D7-0CE602E43F07

P50

Q37309920-128B9BD9-A610-482B-99A8-7DCBF0A21E67

P577

Q37309920-A55B5EBC-6BC5-49CC-BAFC-E667958F64AA

P698

Q37309920-CA77438A-C328-4A3D-9E01-EB58B53DF8D0

P932

Q37309920-2D5A52C0-6CE6-4BFA-8ED6-AA117B1771ED

P356

JNUMED.115.171371

P1433

The Journal of Nuclear Medicine

P1476

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

@en

P2093

Alessandro Ruggiero

http://www.w3.org/2001/XMLSchema#string

David A Scheinberg

http://www.w3.org/2001/XMLSchema#string

José Carlos López Puebla

http://www.w3.org/2001/XMLSchema#string

Katja Behling

http://www.w3.org/2001/XMLSchema#string

Michael R McDevitt

http://www.w3.org/2001/XMLSchema#string

Philip H Gutin

http://www.w3.org/2001/XMLSchema#string

Shanna R Sprinkle

http://www.w3.org/2001/XMLSchema#string

William F Maguire

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization

Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Tumor therapy with targeted atomic nanogenerators.

Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis.

Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.

Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for α-particle radioimmunotherapy of cancer.

Emerging insights into the molecular and cellular basis of glioblastoma.

P304

1576-1582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.115.171371

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Joseph A O'Donoghue

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27127217

http://www.w3.org/2001/XMLSchema#string

P932

5050148

http://www.w3.org/2001/XMLSchema#string